|
Report Date : |
03.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
UNIVERSAL INTEGRATED CORP. |
|
|
|
|
Registered Office : |
5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei
City 10666 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
07.08.1986 |
|
|
|
|
Com. Reg. No.: |
22180049 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Trading of pharmaceutical
products, cosmeceutical products, and healthcare OTC products, etc. |
|
|
|
|
No. of Employees : |
About 170 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
--- |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
5F., No.129, Sec. 1, Fuxing S. Rd., Da-An
District, Taipei City 10666, Taiwan (R.O.C.) |
|
Supplied Address: |
5F, No. 129, Sec 1, Fuxing S. Road, Da-An
District, Taipei City |
|
Telephone Number: |
|
|
Fax Number: |
Notes: The exact name is as above.
|
Credit Opinion: |
|
Registered Name: |
Universal Integrated Corp. |
|
Registered Address: |
5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666,
Taiwan (R.O.C.) |
|
Date of Foundation: |
1986-8-7 |
|
Registration Number: |
22180049 |
|
Registry: |
Taipei City Government |
|
Registered Capital: |
NTD 60,000,000
(USD 1,998,000) (As of 2012.08, 1 NTD = 0.0333 USD) |
|
Paid-up Capital: |
NTD 40,000,000 (USD 1,332,000) |
|
Legal Representatives: |
Xiejun Qiu |
|
Legal Form: |
|
|
Principal Activities: |
Trading of pharmaceutical products, cosmeceutical
products, and healthcare OTC products, etc. |
|
Staff: |
|
|
Listed at Stock
Exchange: |
|
|
Date of Last
Annual Return: |
Subject was incorporated on 1986-8-7 with registered number 22180049 as Joint Stock Company in Taiwan.
|
Name |
Subscription Shares |
|
Xiejun Qiu |
975,000 |
|
Shenxia Song |
770,600 |
|
Weizhong Qiu |
237,200 |
|
Weiqun Qiu |
237,077 |
The information above is that of subject’s major shareholders.
Related Companies
|
1 |
|
|
Name |
Giant &
Medcom Corp. |
|
Address |
5F., No.127,
Sec. 1, Fu-Hsing S. Rd., Da-An District, Taipei City 10666, Taiwan (R.O.C.) |
|
Registered
Number |
30939019 |
|
Date of
Foundation |
1981-3-11 |
|
Telephone Number |
+886-2-2753-3235 |
|
2 |
|
|
Name |
Chin An Trade
Corporation (Translated) |
|
Address |
Room 5, 11
Floor, No.33 Sec2 Jianguo North Road, Zhongshan District, Taipei |
|
Telephone Number |
+886-27523237 |
|
3 |
|
|
Name |
Mai Tong Corporation
(Translated) |
|
Address |
5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666,
Taiwan (R.O.C.) |
Core
Management
|
1 |
|
|
Name |
Xiejun Qiu |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Shenxia Song |
|
Position |
Director |
|
3 |
|
|
Name |
Weizhong Qiu |
|
Position |
Director |
|
4 |
|
|
Name |
Weiqun Qiu |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 170 Employees |
Offices
& Factories
|
|
Headquarters |
|
Add |
5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666,
Taiwan (R.O.C.) |
Production
Information
l
Subject is a trader of pharmaceutical products, cosmeceutical
products, and healthcare OTC products, etc without any production activities.
Purchase
Information
l
The registered activities of subject:
|
Business Code |
Details |
|
F108011 |
Wholesale of traditional Chinese medicine |
|
F108021 |
Wholesale of western medicine |
|
F208011 |
Retail of traditional Chinese medicine |
|
F208021 |
Retail of western medicine |
|
F108031 |
Wholesale of medical equipment |
|
F208031 |
Retail of medical equipment |
|
F401021 |
Importing of RF equipment controlled by telecom |
|
F113070 |
Wholesale of telecom equipment |
|
F213060 |
Retail of telecom equipment |
|
E605010 |
Installation of computer equipment |
|
F113050 |
Wholesale of computer and working equipment |
|
F213030 |
Retail of computer and working equipment |
|
F108040 |
Wholesale of cosmetic |
|
F208040 |
Retail of cosmetic |
|
F102170 |
Wholesale of food and groceries |
|
F203010 |
Retail of food and groceries |
|
F102040 |
Wholesale of drink |
|
F401010 |
International trade business |
|
F107080 |
Wholesale of environmental medicine |
|
J303010 |
Magazine industry |
|
J305010 |
Audio publishing industry |
|
E701010 |
Communication engineering |
|
ZZ99999 |
Besides licensed business, all other business items
those are not banned or restricted. |
l
It is introduced that subject purchases products
from Europe, America, Japan, and Taiwan, etc.
l
Subject is engaged in sales of pharmaceutical
products, cosmeceutical products, and healthcare OTC products, etc.
l
It is introduced that
subject’s sales region is in Taiwan domestic market.
l
Subject is the agency of many brands, such as
“Xanthium”, “Erispan”, “Salagen”, “Fleet”, “Summers Eve”, and “FlexNow”, etc.
l
Subject’s customers include hospitals, clinics, and
supermarkets, etc.
Major products
sold
|
Brand |
Function |
Original |
|
Fleet Enema |
Purging gut |
America |
|
Polyxal |
Restoring scar |
-- |
|
Xanthium |
Depressing respiratory tract obstruction |
-- |
|
Urinom |
Depressing uric acid |
Japan |
|
Progor |
Resisting high blood pressure |
Belgium |
|
Acure |
Treating acne |
America |
|
Salagen |
Treating mouth dry disease |
America |
|
Erispan |
Resisting dysphoria |
-- |
|
Fenogal |
Depressing blood-fat |
Belgium |
|
Summer’s eve |
Cleaning vagina |
America |
|
Sensimin |
Skin care |
Japan |
|
Gyn hydralin |
Cleaning skin |
Taiwan |
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase (Taiwan)
|
Payment Terms |
Proportion |
|
|
Pharmaceutical, cosmeceutical, and healthcare OTC
products |
COD, CBD, etc |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Pharmaceutical, cosmeceutical, and healthcare OTC
products |
CBD, etc |
100% |
Sales
Domestic Markets (Taiwan)
|
Sales Terms |
Proportion |
|
|
Pharmaceutical, cosmeceutical, and healthcare OTC
products |
COD, CBD, Credit Sales, etc |
100% |
Export
Subject has little export.
Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.
Subject’s relevant staff Ms. Zhang declined to disclose its financials citing the grounds of company’s confidentiality; from other source we can not obtain the relevant information, either.
Subject declined to disclose its bank details; from other source we
cannot obtain the relevant information, either.
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
|
2008,beijian,4482 |
|
|
Trial Date: |
|
|
Trial Cause of Action |
Payment for goods |
|
Name |
Ms. Zhang |
|
Department |
Sales Department |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.78 |
|
UK Pound |
1 |
Rs.86.75 |
|
Euro |
1 |
Rs.68.32 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.